Notice of General Meeting/Proxy Form
Released
Released
Announcement PDF
ASX Announcement
Released 2nd July
Dear Shareholder,
General Meeting – Notice of Meeting and Proxies
Notice is given that the General Meeting (Meeting) of Shareholders of Brazilian Critical Minerals Limited
(ACN 089 221 634) (Company) will be held as follows:
Time and date:
10:00am (AWST) on Tuesday, 5 August 2025
In-person:
Office of Argus Corporate Partners, Lvl 4, 225 St Georges Terrace, PERTH WA
6000
Notice of Meeting
In accordance with the Corporations Act 2001 (Cth) the Company will not be dispatching physical
copies of the Notice of Meeting unless the shareholder has made a valid election to receive documents
in hard copy. Instead, the Notice of Meeting and accompanying explanatory statement (Meeting
Materials) are being made available to shareholders electronically and can be viewed and downloaded
from:
• the Company’s website at www.braziliancriticalminerals.com and
• the ASX market announcements page under the Company’s code “BCM”.
If you have nominated an email address and have elected to receive electronic communications from
the Company, you will also receive an email to your nominated email address with a link to an electronic
copy of the Notice of Meeting.
Voting at the Meeting or by proxy
Shareholders are encouraged to vote by lodging a Proxy Form.
The Directors instruct all Shareholders who would like to have their vote counted to vote by lodging a
Proxy Form prior to 10:00am (AWST) on Sunday, 3 August 2025 (Proxy Cut-Off Time). Shareholders
are strongly urged to vote by lodging a Proxy Form prior to the Meeting.
Proxy Forms can be lodged:
• Online:
https://investor.automic.com.au/#/loginsah
• By mail:
Automic, GPO Box 5193, Sydney NSW 2001
• In-person:
Automic, Level 5, 126 Phillip Street, Sydney NSW 2000
• By email:
meetings@automicgroup.com.au
• By fax:
+61 2 8583 3040
• By mobile:
Scan the QR Code on your Proxy Form and follow the prompts
In order for your proxy to be valid, your Proxy Form (and any power of attorney under which it is signed)
must be received by the Proxy Cut-Off Time. Proxies received after this time will be invalid.
The Meeting Materials should be read in their entirety. If shareholders are in doubt as to how they should
vote, they should seek advice from their professional advisers prior to voting.
Authorised for release by:
Ben Donovan
Company Secretary
Brazilian Critical Minerals Limited
Brazilian Critical Minerals Ltd (ABN: 82 089 221 634)
AUS: Level 28, 140 St Georges Terrace, Perth WA 6000 T +61 8 6383 7820
BRA: Av Jornalista Riccardo Marinho, 360, Sala 113, Barra da Tijuca, Rio de Janeiro T +55 21 2439 57
BRAZILIAN CRITICAL MINERALS
ACN 089 221 634
NOTICE OF GENERAL MEETING
Notice is given that the Meeting will be held at:
TIME:
10am WST
DATE:
Tuesday 5 August 2025
PLACE:
The offices of Argus Corporate Partners Pty Ltd, Level 4, 225 St Georges Terrace
Perth WA 6000
The business of the Meeting affects your shareholding and your vote is important.
This Notice should be read in its entirety. If Shareholders are in doubt as to how they should vote,
they should seek advice from their professional advisers prior to voting.
The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001
(Cth) that the persons eligible to vote at the Meeting are those who are registered Shareholders at
5pm WST on Sunday 3 August 2025.
BUSINESS OF THE MEETING
AGENDA
1.
RESOLUTION 1 – RATIFICATION OF PRIOR ISSUE OF TRANCHE 1 SHARES UNDER PLACEMENT LISTING RULE 7.1
To consider and, if thought fit, to pass, with or without amendment, the following resolution
as an ordinary resolution:
“That, for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders
ratify the issue of 157,568,788 Shares on the terms and conditions set out in the
Explanatory Statement.”
2.
RESOLUTION 2 – RATIFICATION OF PRIOR ISSUE OF TRANCHE 1 SHARES UNDER PLACEMENT LISTING RULE 7.1A
To consider and, if thought fit, to pass, with or without amendment, the following resolution
as an ordinary resolution:
“That, for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders
ratify the issue of 90,005,859 Shares on the terms and conditions set out in the
Explanatory Statement.”
3.
RESOLUTION 3 – APPROVAL TO ISSUE TRANCHE 2 SHARES UNDER PLACEMENT
To consider and, if thought fit, to pass, with or without amendment, the following resolution
as an ordinary resolution:
“That, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given
for the Company to issue 251,175,353 Shares to Tranche 2 Participants on the terms
and conditions set out in the Explanatory Statement.”
4.
RESOLUTION 4 – APPROVAL TO ISSUE FREE ATTACHING OPTIONS TO PLACEMENT
PARTICIPANTS
To consider and, if thought fit, to pass, with or without amendment, the following resolution
as an ordinary resolution:
“That, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given
for the Company to issue up to 166,250,000 Placement Options to Placement
Participants, on the terms and conditions set out in the Explanatory Statement.”
5.
RESOLUTION 5 – APPROVAL TO ISSUE OPTIONS TO LEAD MANAGER AND CORPORATE
ADVISOR
To consider and, if thought fit, to pass, with or without amendment, the following resolution
as an ordinary resolution:
“That, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given
for the Company to issue up to 166,250,000 Lead Manager Options to Gaia Natural
Capital on the terms and conditions set out in the Explanatory Statement.”
6.
RESOLUTION 6 – APPROVAL FOR DIRECTOR PARTICIPATION IN PLACEMENT – MR NICHOLAS
HOLTHOUSE
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That, for the purposes of Listing Rule 10.11 and for all other purposes, approval is
given for the Company to issue 1,250,000 Shares and 416,666 Placement Options to
Mr Nicholas Holthouse (or his nominee(s)) on the terms and conditions set out in the
Explanatory Statement.”
7.
RESOLUTION 7 – APPROVAL TO ISSUE SHARES TO RAISE FUNDS FOR GENERAL WORKING
CAPITAL
To consider and, if thought fit, to pass, with or without amendment, the following resolution
as an ordinary resolution:
1
“That, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given
for the Company to issue up to 150,000,000 Shares to professional and institutional
investors on the terms and conditions set out in the Explanatory Statement.”
Dated: 2 July 2025
2109-05/3723765_1
2
Voting Exclusion Statements
In accordance with Listing Rule 14.11, the Company will disregard any votes cast in favour of the
Resolution set out below by or on behalf of the following persons:
Resolution 1 – Ratification of
Prior Issue of Tranche 1 Shares
under Listing Rule 7.1
Resolution 2 – Ratification of
Prior Issue of Tranche 1 Shares
under Listing Rule 7.1A
Tranche 1 Participants or any other person who participated in the issue or an
associate of that person or those persons.
Resolution 3 – Approval to issue
Tranche 2 Shares under
Placement
Tranche 2 Participants or any other person who is expected to participate in, or
who will obtain a material benefit as a result of, the proposed issue (except a
benefit solely by reason of being a holder of ordinary securities in the Company)
or an associate of that person (or those persons).
Placement Participants or any other person who is expected to participate in,
or who will obtain a material benefit as a result of, the proposed issue (except a
benefit solely by reason of being a holder of ordinary securities in the Company)
or an associate of that person (or those persons)).
Gaia Natural Capital or any other person who is expected to participate in, or
who will obtain a material benefit as a result of, the proposed issue (except a
benefit solely by reason of being a holder of ordinary securities in the Company)
or an associate of that person (or those persons).
Mr Nicholas Holthouse (or their nominee(s)) and any other person who will
obtain a material benefit as a result of the issue of the securities (except a
benefit solely by reason of being a holder of ordinary securities in the Company)
or an associate of that person or those persons.
Professional and institutional investors who may elect to participate in the
proposed issue and any other person who is expected to participate in, or who
will obtain a material benefit as a result of, the proposed issue (except a benefit
solely by reason of being a holder of ordinary securities in the Company) or an
associate of that person (or those persons).
Resolution 4 – Approval to issue
Free Attaching Options to
Placement Participants
Resolution 5 – Approval to issue
Options to Lead Manager and
Corporate Advisor
Resolution 6 – Approval for Mr
Nicholas Holthouse to
participate in Placement
Resolution 7 – Approval to issue
Shares to raise funds for general
working capital
Tranche 1 Participants or any other person who participated in the issue or an
associate of that person or those persons.
However, this does not apply to a vote cast in favour of the Resolution by:
(a)
a person as a proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with the directions given to the proxy or attorney to vote on the Resolution in
that way; or
(b)
the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with a direction given to the Chair to vote on the Resolution as the Chair
decides; or
(c)
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf
of a beneficiary provided the following conditions are met:
(i)
the beneficiary provides written confirmation to the holder that the beneficiary is
not excluded from voting, and is not an associate of a person excluded from
voting, on the Resolution; and
(ii)
the holder votes on the Resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
2109-05/3723765_1
3
Voting by proxy
To vote by proxy, please complete and sign the enclosed Proxy Form and return by the time and in
accordance with the instructions set out on the Proxy Form.
In accordance with section 249L of the Corporations Act, Shareholders are advised that:
•
each Shareholder has a right to appoint a proxy;
•
the proxy need not be a Shareholder of the Company; and
•
a Shareholder who is entitled to cast two or more votes may appoint two proxies and may
specify the proportion or number of votes each proxy is appointed to exercise. If the
Shareholder appoints two proxies and the appointment does not specify the proportion or
number of the member’s votes, then in accordance with section 249X(3) of the
Corporations Act, each proxy may exercise one-half of the votes.
Shareholders and their proxies should be aware that:
•
if proxy holders vote, they must cast all directed proxies as directed; and
•
any directed proxies which are not voted will automatically default to the Chair, who must
vote the proxies as directed.
Voting in person
To vote in person, attend the Meeting at the time, date and place set out above.
Should you wish to discuss the matters in this Notice please do not hesitate to contact the Company
Secretary on +61 0401 248 048.
2109-05/3723765_1
4
EXPLANATORY STATEMENT
This Explanatory Statement has been prepared to provide information which the Directors believe
to be material to Shareholders in deciding whether or not to pass the Resolutions.
1.
BACKGROUND TO PLACEMENT
1.1
General
On 5 June 2025, the Company announced that it had received binding commitments from
professional and institutional investors (Placement Participants) to raise $3,990,000 (before
costs) under a two-tranche share placement (Placement). The use of the funds raised
under the Placement is set out in Section 1.2.
The first tranche of the Placement comprised 247,574,647 Shares (Tranche 1 Shares) which
were issued to issued to professional and institutional investors (Tranche 1 Participants) at
an issue price of $0.008 per Share to raise $1,980,597 (Tranche 1). The Tranche 1 Shares
were issued on 13 June 2025 pursuant to the Company’s placement capacity under ASX
Listing Rules 7.1 and 7.1A.
The second tranche of the Placement comprises of 251,175,353 Shares (Tranche 2 Shares)
to be issued professional and institutional investors (Tranche 2 Participants) at an issue price
of $0.008 per Share to raise $2,009,403 (Tranche 2). The issue of the Tranche 2 Shares is
subject to Shareholder approval under Resolution 3 for the purposes of Listing Rule 7.1.
Under the terms of the Placement, Placement Participants will receive one (1) freeattaching unlisted option (Option) for every three (3) new Shares subscribed for under the
Placement, exercisable at $0.011 per Option expiring on the date that is two (2) years after
the Options are issued (Placement Options). The terms of the Placement Options are further
stated in Schedule 1. The issue of the Placement Options is subject to the Company
receiving Shareholder approval under Resolution 4.
Mr Nicholas Holthouse, a director of the Company, has subscribed for Securities under the
Placement. The participation of Mr Holthouse in the Placement is subject to the Company
obtaining Shareholder approval under Listing Rule 10.11 pursuant to Resolution 6 at the
Meeting. Further details of the Director participation in the Placement is set out in Section
6 below.
1.2
Use of Funds
Proceeds from the Placement will allow the Company to accelerate workstreams at its
flagship Ema Rare Earths Project in Brazil. Funds raised from the Placement are intended to
be applied towards:
(a)
advancing the EMA Rare Earths Project, including commencing a bankable
feasibility study;
(b)
completing pilot field trials utilising in-situ recovery techniques;
(c)
progressing offtake negotiations;
(d)
progressing permitting and environmental studies;
(e)
providing general working capital; and
(f)
covering costs of the Placement.
Further details in respect of the Placement are set out in the Company’s announcement
on its ASX platform released on 5 June 2025.
1.3
Lead Manager and Corporate Advisor Engagement
The Company engaged Gaia Natural Capital Pty Ltd (ACN 655 598 422) (Gaia Natural
Capital) as lead manager and corporate advisor in relation to the Placement.
As part of the consideration for the services provided by Gaia Natural Capital, the
Company will issue Gaia Natural Capital with one (1) Option for every three (3) Shares
issued under the Placement, exercisable at $0.011 on or before the date that is three (3)
2109-05/3723765_1
5
years from the date of issue (Lead Manager Options). The Company has also agreed to
make a cash payment to Gaia Natural Capital for services provided equal to 6% of the
total amount raised under the Placement, this being a maximum of $239,400.
The Lead Manager Options are to be issued on the terms and conditions stated in
Schedule 2. The issue of the Lead Manager Options is subject to Shareholder approval
under Resolution 5 for the purposes of Listing Rule 7.1.
2.
RESOLUTIONS 1 AND 2 – RATIFICATION OF PRIOR ISSUE OF SHARES UNDER THE PLACEMENT
2.1
General
These Resolutions seek Shareholder ratification for the purposes of Listing Rule 7.4 for the
issue of an aggregate of 247,574,647 Shares at an issue price of $0.008 per Share to raise
$1,980,597.
157,568,788 Shares were issued on 13 June 2025 pursuant to the Company’s capacity
under Listing Rule 7.1 (being, the subject of Resolution 1) and 90,005,859 Shares pursuant
to the Company’s placement capacity under Listing Rule 7.1A (being, the subject of
Resolution 2).
2.2
Listing Rules 7.1 and 7.1A
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount
of equity securities that a listed company can issue without the approval of its shareholders
over any 12 month period to 15% of the fully paid ordinary securities it had on issue at the
start of that 12 month period.
Under Listing Rule 7.1A however, an Eligible Entity can seek approval from its members, by
way of a special resolution passed at its annual general meeting, to increase this 15% limit
by an extra 10% to 25%. The Company obtained this approval at its annual general
meeting held on 28 November 2024.
The issue does not fit within any of the exceptions set out in Listing Rule 7.2 and, as it has
not yet been approved by Shareholders, it effectively uses up part of the 25% limit in Listing
Rules 7.1 and 7.1A, reducing the Company’s capacity to issue further equity securities
without Shareholder approval under Listing Rule 7.1 and 7.1A for the 12 month period
following the date of the issue.
2.3
Listing Rule 7.4
Listing Rule 7.4 allows the shareholders of a listed company to approve an issue of equity
securities after it has been made or agreed to be made. If they do, the issue is taken to
have been approved under Listing Rule 7.1 and so does not reduce the company’s
capacity to issue further equity securities without shareholder approval under that rule.
The Company wishes to retain as much flexibility as possible to issue additional equity
securities in the future without having to obtain Shareholder approval for such issues under
Listing Rule 7.1. Accordingly, the Company is seeking Shareholder ratification pursuant to
Listing Rule 7.4 for the issue.
2.4
Technical information required by Listing Rule 14.1A
If these Resolutions are passed, the issue will be excluded in calculating the Company’s
combined 25% limit in Listing Rules 7.1 and 7.1A, effectively increasing the number of equity
securities the Company can issue without Shareholder approval over the 12 month period
following the date of the issue.
If these Resolutions are not passed, the issue will be included in calculating the Company’s
combined 25% limit in Listing Rules 7.1 and 7.1A, effectively decreasing the number of
equity securities the Company can issue without Shareholder approval over the 12 month
period following the date of the issue.
2109-05/3723765_1
6
2.5
Technical information required by Listing Rules 7.4 and 7.5
REQUIRED INFORMATION
DETAILS
Names of persons to whom
Securities were issued or the
basis on which those persons
were identified/selected
Professional and sophisticated investors who were identified
through a bookbuild process, which involved Gaia Natural
Capital seeking expressions of interest to participate in the
capital raising from non-related parties of the Company.
Persons were issued more than 1% of the issued capital of
the Company.
Number and class of
Securities issued
247,574,647 Shares were issued on the following basis:
(a)
157,568,788 Shares were issued under Listing Rule
7.1 (ratification of which is sought under Resolution
1); and
(b)
90,005,859 Shares issued pursuant to Listing Rule
7.1A (ratification of which is sought under
Resolution 2).
Terms of Securities
The Shares were fully paid ordinary shares in the capital of
the Company issued on the same terms and conditions as
the Company’s existing Shares.
Date(s) on or by which the
Securities were issued
13 June 2025
Price or other consideration
the Company received for
the Securities
$0.008 per Share for Shares issued pursuant to Listing Rule 7.1
and Listing Rule 7.1A.
Purpose of the issue,
including the intended use of
any funds raised by the issue
Refer to Section 1.2 for details of the proposed use of funds.
Summary of material terms of
agreement to issue
The Shares are not being issued pursuant to an agreement.
Voting Exclusion Statement
A voting exclusion statement applies to this Resolution.
Compliance
The issue did not breach Listing Rule 7.1.
3.
RESOLUTION 3 – APPROVAL TO ISSUE TRANCHE 2 SHARES UNDER PLACEMENT
3.1
General
This Resolution seeks Shareholder approval for the purposes of Listing Rule 7.1 for the issue
of 251,175,353 Shares to Tranche 2 Participants at an issue price of $0.008 per Share to raise
up to $2,009,402.
A summary of Listing Rule 7.1 is set out in Section 2.2 above.
The proposed issue falls within exception 17 of Listing Rule 7.2. It therefore requires the
approval of Shareholders under Listing Rule 7.1
3.2
Technical information required by Listing Rule 14.1A
If this Resolution is passed, the Company will be able to proceed with the issue. In addition,
the issue will be excluded from the calculation of the number of equity securities that the
Company can issue without Shareholder approval under Listing Rule 7.1.
If this Resolution is not passed, the Company will not be able to proceed with the issue. The
Company will therefore not be able to raise an additional $2,009,402 under the Placement.
2109-05/3723765_1
7
3.3
Technical information required by Listing Rule 7.3
REQUIRED INFORMATION
DETAILS
Names of persons to whom
Securities will be issued or the
basis on which those persons
were or will be
identified/selected
Professional and sophisticated investors who were identified
through a bookbuild process, which involved Gaia Natural
Capital seeking expressions of interest to participate in the
capital raising from non-related parties of the Company.
Number of Securities and
class to be issued
251,175,353 Shares will be issued.
Terms of Securities
The Shares will be fully paid ordinary shares in the capital of
the Company issued on the same terms and conditions as
the Company’s existing Shares.
Date(s) on or by which the
Securities will be issued
The Company expects to issue the Shares within 5 Business
Days of the Meeting. In any event, the Company will not
issue any Shares later than three months after the date of
the Meeting (or such later date to the extent permitted by
any ASX waiver or modification of the Listing Rules).
Price or other consideration
the Company will receive for
the Securities
$0.008 per Share.
Purpose of the issue,
including the intended use of
any funds raised by the issue
Refer to Section 1.2 for details of the proposed use of funds.
Summary of material terms of
agreement to issue
The Shares are not being issued pursuant to an agreement.
Voting exclusion statement
A voting exclusion statement applies to this Resolution.
4.
RESOLUTION 4 – APPROVAL TO ISSUE FREE ATTACHING OPTIONS TO PLACEMENT
PARTICIPANTS
4.1
General
This Resolution seeks Shareholder approval for the purposes of Listing Rule 7.1 for the issue
of 166,250,000 Placement Options to Placement Participants. Under the Placement,
Placement Participants are entitled to receive one (1) Placement Option for every three
(3) Shares subscribed for and issued. The Placement Options will be exercisable at $0.011
each on or before the date that is three (3) years from the date of issue and otherwise on
the terms and conditions set out in Schedule 1.
A summary of Listing Rule 7.1 is set out in Section 2.2 above.
The proposed issue does not fall within any of the exceptions set out in Listing Rule 7.2 and
exceeds the 15% limit in Listing Rule 7.1. It therefore requires the approval of Shareholders
under Listing Rule 7.1.
4.2
Technical information required by Listing Rule 14.1A
If this Resolution is passed, the Company will be able to proceed with the issue. In addition,
the issue will be excluded from the calculation of the number of equity securities that the
Company can issue without Shareholder approval under Listing Rule 7.1.
If this Resolution is not passed, the Company will not be able to proceed with the issue.
Placement Participants will therefore not be able to receive the Placement Options under
the Placement.
4.3
Technical information required by Listing Rule 7.3
REQUIRED INFORMATION
DETAILS
Names of persons to whom
Securities will be issued or the
Placement Participants who were identified through a
bookbuild process which involved Gaia Natural Capital
2109-05/3723765_1
8
REQUIRED INFORMATION
DETAILS
basis on which those persons
were or will be
identified/selected
seeking expressions of interest to participate in the capital
raising from non-related parties of the Company.
Number of Securities and
class to be issued
166,250,000 Placement Options will be issued.
Terms of Securities
The Placement Options will be issued on the terms and
conditions set out in Schedule 1.
Date(s) on or by which the
Securities will be issued
The Company expects to issue the Options within 5 Business
Days of the Meeting. In any event, the Company will not
issue any Options later than three months after the date of
the Meeting (or such later date to the extent permitted by
any ASX waiver or modification of the Listing Rules).
Price or other consideration
the Company will receive for
the Securities
The Company will not receive any initial consideration from
the issue of the Placement Options as the Options will be
free attaching on the basis of one (1) Placement Option for
every three (3) new Shares subscribed for under the
Placement.
Purpose of the issue,
including the intended use of
any funds raised by the issue
The Placement Options are free-attaching options to
incentivise investment in the Company.
Summary of material terms of
agreement to issue
The Placement Options are not being issued pursuant to an
agreement.
Voting exclusion statement
A voting exclusion statement applies to this Resolution.
The Company confirms that no Material Persons will be
issued more than 1% of the issued capital of the Company.
5.
RESOLUTION 5 – APPROVAL TO ISSUE OPTIONS TO LEAD MANAGER AND CORPORATE
ADVISOR
5.1
General
This Resolution seeks Shareholder approval for the purposes of Listing Rule 7.1 for the issue
of 166,250,000 Lead Manager Options in consideration for lead managerial and corporate
advisory services provided by Gaia Natural Capital.
A summary of Listing Rule 7.1 is set out in Section 2.2 above.
The proposed issue falls within exception 17 of Listing Rule 7.2. The proposed issue therefore
requires the approval of Shareholders under Listing Rule 7.1.
5.2
Technical information required by Listing Rule 14.1A
If this Resolution is passed, the Company will be able to proceed with the issue. In addition,
the issue will be excluded from the calculation of the number of equity securities that the
Company can issue without Shareholder approval under Listing Rule 7.1.
If this Resolution is not passed, the Company will not be able to proceed with the issue. If
this Resolution is not passed, the Company will not be able to proceed with the issue. The
Company may be required to renegotiate terms with Gaia Natural Capital, which may
involve the Company paying an additional cash fee.
5.3
Technical information required by Listing Rule 7.3
REQUIRED INFORMATION
DETAILS
Names of persons to whom
Securities will be issued or the
basis on which those persons
were or will be
identified/selected
Gaia Natural Capital (or their nominee(s)).
2109-05/3723765_1
The Company confirms that no Material Persons will be
issued more than 1% of the issued capital of the Company.
9
REQUIRED INFORMATION
DETAILS
Number of Securities and
class to be issued
166,250,000 Lead Manager Options will be issued.
Terms of Securities
The Lead Manager Options will be issued on the terms and
conditions set out in Schedule 2.
Date(s) on or by which the
Securities will be issued
The Company expects to issue the Securities within 5 Business
Days of the Meeting. In any event, the Company will not
issue any Securities later than three months after the date of
the Meeting (or such later date to the extent permitted by
any ASX waiver or modification of the Listing Rules).
Price or other consideration
the Company will receive for
the Securities
The Lead Manager Options will be issued at a nil issue price,
in consideration for lead managerial and corporate
advisory services provided by Gaia Natural Capital.
Purpose of the issue,
including the intended use of
any funds raised by the issue
The purpose of the issue is to satisfy the Company’s
obligations under the lead manager and corporate advisor
mandate.
Summary of material terms of
agreement to issue
The Lead Manager Options are being issued under the lead
manager and corporate advisor mandate, a summary of
the material terms of which is set out in Section 1.3.
Voting exclusion statement
A voting exclusion statement applies to this Resolution.
6.
RESOLUTION 6 – APPROVAL FOR MR NICHOLAS HOLTHOUSE TO PARTICIPATE IN PLACEMENT
6.1
General
This Resolution seeks Shareholder approval for the purposes Listing Rule 10.11 for the issue
of 1,250,000 Shares and 416,666 Placement Options to Mr Nicholas Holthouse (or their
nominee(s)) to enable their participation in the Company’s Placement on the same terms
as unrelated participants.
6.2
Chapter 2E of the Corporations Act
Chapter 2E of the Corporations Act requires that for a public company, or an entity that
the public company controls, to give a financial benefit to a related party of the public
company, the public company or entity must:
(a)
obtain the approval of the public company’s members in the manner set out in
sections 217 to 227 of the Corporations Act; and
(b)
give the benefit within 15 months following such approval,
unless the giving of the financial benefit falls within an exception set out in sections 210 to
216 of the Corporations Act.
The issue constitutes giving a financial benefit and each of the proposed recipients is a
related party of the Company by virtue of being a Director.
The Directors (other than Mr Nicholas Holthouse who has a material personal interest in the
Resolution) consider that Shareholder approval pursuant to Chapter 2E of the Corporations
Act is not required in respect of the issue because the Securities will be issued to Mr
Holthouse (or their nominee(s)) on the same terms as Securities issued to non-related party
participants in the capital raising and as such the giving of the financial benefit is on arm’s
length terms.
6.3
Listing Rule 10.11
Listing Rule 10.11 provides
Share your feedback
Discover